1960

1960-1977

New technological flows are developed that manufacture various active ingredients (erythromycin, oxytetracycline, tetracycline, griseofulvin, synerdol, lysine). Throughout this period Antibiotice becomes the single manufacturer of sterile products for parenteral use (injectables) in Romania. In 1977 the Streptomycin manufacture obtained the authorization granted by the US regulatory body, the Food and Drug Administration which opened the way to the international markets.